ELLIOTT PERLIN; PETER NIELSEN; DAVID KARP; ALVIN WATNE, M.D.; JOHN L. ZIEGLER, M.D.
To the editor: Meningeal extension of Burkitt's lymphoma is particularly dreaded because it presages a poor prognosis. Although many patients initially respond to therapy, relapse is common (1).
We have treated a patient who had Burkitt's lymphoma, in the central nervous system, with combined systemic, intrathecal, and cranial radiation therapy. We report our results because experience with this disease in the United States has been limited.
The patient was a 17-year-old white woman who was living in Bitburg, Germany, when she noted an enlarged lymph node in the left axilla. A biopsy specimen taken on 6 February 1973 showed lymphosarcoma,
PERLIN E, NIELSEN P, KARP D, WATNE A, ZIEGLER JL. Therapy of Burkitt's Lymphoma in the Central Nervous System. Ann Intern Med. ;81:408–409. doi: 10.7326/0003-4819-81-3-408
Download citation file:
Published: Ann Intern Med. 1974;81(3):408-409.
Hematology/Oncology, Infectious Disease, Leukemia/Lymphoma, Neurology.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use